The global disposable insulin-delivery device market is projected to experience robust growth over the next decade, according to recent industry insights. Valued at USD 14,585.6 million in 2022, the ...

DexCom DXCM recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use glucose ...

The G7 sensor can now be integrated with Omnipod 5 Automated Insulin Delivery System, NovoPen 6, and NovoPen Echo Plus, expanding its utility. Dexcom also remains the only CGM provider offering ...

First, the company announced that its G7 sensor directly connects with Novo Nordisk’s NovoPen 6 and NovoPen Echo Plus in Germany. Additionally, the company highlighted new data for its 15-day CGM, ...